ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666869 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666869; 2) Community: the network communities that were significantly associated with the response to NSC 666869; 3) Molecule: the relationships between components within communities and NSC 666869; 4) MDR: the compounds that were significantly associated with the NSC 666869.

NSC Compound Enrichment Correlation
NSC 700583 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.00311751113090895 -0.089486663
NSC 730632 {6-(3-Amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylen edioxy-5,11-dioxo-11H-indeno[1,2-c]-isoquinoline}-{5',6'-Dih ydro-6'-(3'-amino-1'-propyl)-5',11'-dioxo-11'H-indeno[1,2-c] -isoquinoline}pr 0.00311751113090895 0.012632356
NSC 751548 Fluka catalog #46729 0.00311751113090895 0.28176013
NSC 758230 Floxuridine (USAN) 0.00311751113090895 0.20921156
NSC 673791 Null 0.00385572727186 0.021102267
NSC 181500 Null 0.00385572727186009 0.068406294
NSC 631197 9-N-(N'-chloroethyl-N'-ethyl-1,4-diamino-butyl)2-methoxy acridine dihydrochloride 0.00385572727186009 0.2629026
NSC 646604 Null 0.00385572727186009 0.080614459
NSC 703105 Null 0.00396220821750022 -0.047080548
NSC 295500 Camptothecin Derivative 0.00396220821750028 0.36453533
Total:59  Current:4    [First] [Prev] [Next] [Last]